A Phase 2b, Placebo-Controlled, Randomized, Observer-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tetanus, Diphtheria, and Acellular Pertussis

A Study to Test the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine When Administered With Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Tdap) in Healthy, Nonpregnant Women Aged 18 to 49 Years

Category & Conditions: Vaccine-related Conditions

Medicine: PF-06760805

ClinicalTrials.gov Identifier (NCT): NCT04766086

Protocol ID: C1091005

Print Download

Open Plain Language Summary Result: Click here